Job Description Summary
Office Location: London (The Westworks), United Kingdom#LI-Hybrid Hybrid (12 days per month on-site if living within 50 miles of our London office)
#LI-Remote Remote (if living beyond 50 miles of our London office)
About the role:
We are in search of a Senior Principal Biostatistician to join a passionate team within Advanced Quantitative Sciences. Come to an industry leader where you will lead implementation of modern and innovative trial/experimental designs, statistical models, analysis and data exploration methodologies at the study level and you will be responsible for all statistical work, scientific and operational, in collaboration with the clinical trial teams and other quantitative partners
Job Description
Your Key Responsibilities:
- Responsible for all statistical tasks on the assigned trials.
- Protocol development in alignment with the development plan, developing statistical analysis plan, reporting activities.
- Contribute to planning and execution of exploratory analyses and statistical consultation within your cross-functional teams.
- Initiate, drive and implement novel methods and innovative trial designs in alignment with the Lead Statistician.
- Collaborate with clinical, regulatory and other strategic functions to drive quantitative decision making in assigned indications/program with oversight.
- Collaborate cross-functionally (e.g. data management, programming, medical writing) to ensure timeliness and quality of statistical deliverables.
- Contribute to external engagement with consultants, advisory boards, health authorities, congresses, and scientific meetings
Role Requirements:
Essential Requirements:
- PhD experience preferred OR MS with extensive experience
- Fluent English (oral and written)
- Strong communication and presentation skills
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture
Benefits and Rewards: Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: https://www.novartis.com/careers/benefits-rewards
Skills Desired
Automation, Biostatistics, Clinical Trials, Computer Programming, Metadata Management, Statistical AnalysisSkills Required
- PhD or MS with extensive experience
- Fluent English (oral and written)
- Strong communication and presentation skills
Novartis Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Novartis and has not been reviewed or approved by Novartis.
-
Healthcare Strength — Pay and benefits are described as a strong overall package, supported by medical, dental, and vision insurance alongside FSAs/HSAs and disability and life coverage. Mental-health support is reinforced through an employee assistance program with psychological support and a network of mental health first aiders.
-
Retirement Support — Retirement support is positioned as a standout element, with an automatic company contribution plus dollar-for-dollar matching in the 401(k). Additional retirement funding is described through an age-based defined contribution program and access to an employee share purchase plan discount.
-
Parental & Family Support — Family-related benefits are framed as robust, including a global minimum of paid parental leave for new parents following birth or adoption. Added supports include domestic partner coverage, dependent-care resources, and benefits such as adoption assistance and child/elder care options.
Novartis Insights
What We Do
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
